All Articles
Browse every published article, from the latest research to earlier analysis. Use the page numbers below to explore the complete archive.
Does Oral CBD Turn Into THC in the Stomach? What a Three-Minipig Study Actually Measured
Three minipigs received oral CBD. Plasma and gut THC and 11-OH-THC stayed below assay limits. Learn what that means—and does not prove—for forensic tests.
Can Urine Fluorescence Identify THC Without GC–MS? Four Cannabinoids, One Small Validation Study
Can urine fluorescence identify THC? A primary 2023 study of four analytes reveals spectral overlap, mixed-model LOQs, and limits of a four-donor validation.
Can CBD Reduce Virus-Triggered Seizures at Two Hours but Not Nine? The TMEV Mouse Evidence
In TMEV-infected mice, CBD 150 mg/kg reduced observed seizures two hours after injection, not nine hours. Read the primary study, safety signals and limits.
Does Acute Cold Stress Release Stored THC Into Plasma? A 15-Person Study
A primary cold-water immersion study in 15 cannabis users found higher glycerol and fatty acids but no significant rise in plasma THC. Matrices, tasks and limits explained.
Can a Smartphone Detect Slower Movement After Cannabis Concentrates When Plasma THC Poorly Predicts It? A 65-User Study
A 65-user cannabis concentrate study found slower arm and leg movement and acute sway changes, but tapping nulls and weak plasma THC correlations cannot diagnose impairment.
Do CBD–THC Nanoemulsions Delay Seizures Without Restoring Memory? Two PTZ Mouse Models
Short answer: In a 2025 experiment using male Swiss mice, oral nanoemulsions containing cannabidiol (CBD), delta-9-tetrahydrocannabinol (THC), or a 1:1 combination improved selected seizure outcomes after chemically induced challenges. In a repeated-challenge experiment, CBD at 10 mg/kg and CBD–THC combinations at 1.5 or 3 mg/kg delayed severe seizure development, but the 6 mg/kg combination did…
Can Whole-Blood THC Exceed 5 ng/mL Days After Cannabis Use Without Worse Simulator Driving? A 190-Person Study
In 190 frequent cannabis users, 10 had whole-blood THC ≥5 ng/mL after requested abstinence. Simulator cutpoints did not separate groups in 187 users.
Does Oral THC Reduce Willingness to Work for Rewards? A Controlled Study of 58 Women
A controlled 58-woman study found 15 mg oral THC reduced difficult-task choices, but 7.5 mg was nonsignificant. Separate motivation, motor speed, and blood testing.
Does Smoked Cannabis Cause Aversive Effects in People at Psychosis Risk? What a 12-Person Placebo Study Found
A 12-person placebo study found aversive ratings and selective digit-copy changes after smoked cannabis, but Go/No-Go postdose and N-Back results were null.
Does CYP2C9*3 Lower THC-COOH Without Lowering Plasma THC? Evidence From 66 Driving Cases
In 66 men’s DUID cases, CYP2C9*3 tracked lower plasma THC-COOH, but parent THC was not significantly different. Original GC-MS and forensic limits.
Can THC or CBD Thicken Whole Blood? What a 24-Donor Laboratory Experiment Measured
A 24-donor lab experiment found higher blood viscosity with added THC or CBD. Learn the exact results, null findings, and limits on clinical or DUI claims.
Can CBD Prevent Persistent THC Memory Deficits Despite Higher Plasma THC? A Mouse Study
A complete 2017 mouse study found concurrent CBD attenuated selected THC-related memory and behavioral deficits despite approximately 30% higher measured plasma THC. What it proves—and cannot prove—for forensic impairment.
Can THC Reduce Arthritis-Cell Inflammation While Increasing Other Immune Responses? What 14 Synovial-Tissue Donors Show
Original 2022 study of 14 rheumatoid arthritis tissue donors: THC increased TRPA1-linked calcium, reduced MMP-3 only alongside high-dose cell loss, and changed PBMC cytokines differently. What it cannot prove about human THC or impairment.
Can Cannabis Oils Reverse Aluminum Neurotoxicity? What a 144-Zebrafish Experiment Actually Measured
In 144 zebrafish, cannabis oils altered aluminum-associated social behavior and enzyme assays, but did not restore every tank behavior or establish human treatment.
Can a Negative Urine THC Screen Exclude Exposure After a CBD-Labeled Product? Five Emergency Cases
A five-patient CBD-product emergency study found negative urine THC screening with detected serum THC-COOH. Understand matrices, cutoffs and causation limits.
Did CBD-Rich Cannabis Reduce Plasma Cytokines? What a 23-Man Observational Pilot Found
A primary study of 23 men found a lower plasma cytokine composite after CBD-rich cannabis, but no significant plasma THC difference or memory interaction.
Can 16 ng/mL Whole-Blood THC Accompany Hallucination-Like Symptoms? A Controlled Cannabis Case
A controlled cannabis case reports whole-blood THC 16 ng/mL, acute perceptual symptoms, and route differences. Learn what the evidence cannot prove.
Can Plasma THC and Its Metabolites Predict Recognition-Memory Errors? A 31-User Mobile-Lab Study
In a 31-user mobile-lab study, plasma THC plus metabolites tracked word-recognition accuracy. Learn what d-prime findings cannot prove about a person’s impairment.
Can 11-OH-THC Glucuronide in Serum or Urine Prove Recent Cannabis Impairment? Evidence From a Synthesized Reference Standard
Can 11-OH-THC glucuronide prove impairment? Original synthesis and ten-serum, ten-urine results show what chemistry establishes—and what it cannot.
Can CBD-Dominant Cannabis Oil Produce a Positive Urine THC Screen When Plasma THC Is Mostly Unquantifiable? A 43-Person Trial
Original 43-person controlled study: CBD-rich oil containing THC, urine THC-metabolite screening through 144 hours, and mostly unquantifiable plasma parent THC. Forensic limits.
Does CBD-Rich, Low-THC Exposure Prevent Lasting Memory Effects? What Two Female-Rat Experiments Found
A primary female-rat study found adult recognition-memory deficits after THC, THC-rich/CBD-poor, and CBD-rich/THC-poor adolescent injections, with different stress and brain outcomes. Learn the forensic limits.
Did High-Concentration THC Change Human Blood-Cell Epigenetics? What a 16-Donor Laboratory Study Shows
An original 16-donor cell-culture THC study found dose-dependent DNMT, TET and DNA hydroxymethylation changes—not a blood-THC or driving-impairment test.
Can Wooden-Tip Mass Spectrometry Detect THC at Oral-Fluid Cutoffs? A Primary Laboratory Study
A primary WT-ESI-MS study found a 40,000 ng/mL THC detection limit in fortified urine and oral fluid. Learn why this cannot validate forensic impairment.
Can THC Plus CBD Lower Hippocampal Glutamate Without Restoring Memory Synapses? Evidence From Alzheimer-Model Mice
Original APP/PS1 mouse research found THC plus CBD changed evoked hippocampal glutamate without rescuing LTP or spines. Explore the forensic limits.
Which Tissues Retain JWH-210, RCS-4, and THC After Intravenous Dosing? An 18-Pig Study
Primary forensic data from 18 drug-exposed pigs compare IV JWH-210, RCS-4 and THC in bile, kidneys, lungs, brain, fat and vitreous—without implying human impairment.
Can a Serum Metabolomic Fingerprint Prove Cannabis Impairment? A 35-Person Placebo-Controlled Study
A placebo-controlled human THC study measured serum metabolites and vigilance, but its 80% use-history classifier did not validate individual driving impairment.
Can a Teen Driver Deny Cannabis Use Yet Test THC-Positive? What 718 Roadside Surveys Show
A 718-teen roadside study found 28 denials with positive THC tests and 17 discordant blood/oral-fluid pairs. Why neither proves a lie or impairment.
Can a Sativex Registry Prove THC Does Not Impair Driving? What 941 Prescriber Reports Actually Show
A 941-patient THC/CBD prescription registry noted 63 driving improvements, 19 declines and 514 inapplicable responses. Why it cannot prove individual impairment.
Does Severe Kidney Disease Increase Plasma THC After the Same Cannabis Dose? A 49-Person Study
A primary 49-person study found higher plasma THC and CBD exposure in stage 4–5 CKD after the same Sativex dose; adjusted THC–eGFR association was nonsignificant.
Can THC-Related Liver-Cell Gene Changes Prove Cannabis-Induced Hepatitis? A 2025 Primary Study
A 2025 primary study found THC-related gene changes in cultured liver cells. Learn why predicted targets and qPCR do not prove a patient’s hepatitis.